["{\n\"step_by_step_thinking\": \"The question asks about using serum for analyzing EGFR mutation status in patients with advanced non-small cell lung cancer. The provided documents discuss the expression of epidermal growth factor receptor (EGFR) in various epithelial neoplasms, including pancreatic and glioma cancers. There is no specific information on serum analysis or lung cancer. Therefore, based on the available information, it seems unlikely that serum can be used for analyzing EGFR mutation status in patients with advanced non-small cell lung cancer.\",\n\"answer_choice\": \"B\""]